Global Continuous Renal Replacement Therapy (CRRT) Market to Reach $1.7 Billion by 2026

  • Global competitiveness and percentage market shares of main competitors
  • Market presence in multiple geographies – Strong/Active/Niche/Trivial
  • Peer-to-peer collaborative online interactive updates
  • Access to our digital archives and the MarketGlass research platform
  • Free updates for one year

Editing: 9; Published: February 2022
Executive Pool: 5928
Companies: 18 – Players covered include Asahi Kasei Medical Co., Ltd. ; B. Braun Melsungen AG; Baxter International, Inc.; Bellco Societa Unipersonale arl; Chongqing Shanwaishan Science and Technology Co., Ltd. ; Fresenius Medical Care AG & Co. KgaA; Infomed SA; Medica SpA; Medical Components, Inc.; Medites Pharma Spol. SRO; Medtronic APIs; Nikkiso Co., Ltd. ; Ningbo Tianyi Medical Appliance Co., Ltd; NxStage Medical, Inc.; Toray Medical Co., Ltd. and others.
Cover: All major geographies and key segments
segments: Modality (continuous venovenous hemofiltration, continuous venovenous hemodialysis, continuous venovenous hemodiafiltration, slow continuous filtration); Product (dialysates and replacement fluids, and consumables and systems)
Geographies: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; UK; and rest of Europe); Asia Pacific; Rest of the world.

Free Project Preview – This is an ongoing global program. Preview our research program before making a purchasing decision. We provide free access to qualified executives in strategy, business development, sales and marketing, and product management roles at featured companies. Insights provide insider access to business trends; competing brands; profiles of experts in the field; and market data models and much more. You can also create your own bespoke report using our MarketGlass™ platform which offers thousands of bytes of data with no obligation to purchase our report. Registry overview

ABSTRACT-

Global Continuous Renal Replacement Therapy (CRRT) Market to Reach $1.7 billion by 2026

Continuous renal replacement therapy (CRRT) is the most widely used therapy in critically ill patients, as these hypotensive patients require slow removal of waste and water without causing hypotension. As renal replacement therapy for pediatric patients with acute renal failure (ARI) becomes more common, CRRT is gaining ground as an appropriate treatment modality for patients of any size who are hemodynamically unstable. The rising prevalence of cardiovascular disease is the underlying factor in acute kidney failure cases, which is expected to drive the demand for ERRC. Amid COVID-19 Crisis, Global Continuous Renal Replacement Therapy (CRRT) Market Estimated at US$1.4 billion in 2022, is expected to reach a revised size of US$1.7 billion by 2026, registering a compound annual growth rate (CAGR) of 5.8% over the analysis period. United States represents the largest regional market for Continuous Renal Replacement Therapy (CRRT) and is expected to reach US$422.4 million by 2026. China is expected to spearhead the growth and become the fastest growing regional market with a CAGR of 8.3% over the analysis period.

The global continuous renal replacement therapy (CRRT) market is expected to grow rapidly in the future, driven by the rising incidence of acute kidney injury (ARI). ARI accounts for about 60% of the mortality rate. CRRT is the most widely used treatment for ARI. The technique is the most preferred modality for treating and managing hemodynamically unstable patients with AKI. Advantages of CRRT include hemodynamic tolerance due to solute removal and slower ultrafiltration. Rising aging population, rise in critical care related admissions, and higher acceptance of CRRT procedures due to clinical advantages over intermittent blood purification methods are the other key factors driving the growth of the market. As Renal Replacement Therapy (RRT) is required in patients with severe Acute Kidney Failure (ARI), increasing incidence of Acute Kidney Injury remains a major driver of CRRT market growth. Kidney disorders and kidney disease are also common in older adults, and the surge in the elderly population is swelling the population of potential patients for CRRT treatments.

Europe and United States dominate the continuous renal replacement therapy market, due to the rapid aging of the population and the increase in cases of acute renal failure. Become thin Asia Pacific region is attributable to the increase in the aging population, increasing cases of acute kidney injury/disease, rising healthcare costs, advances in technology and pressure from governments to invest in the healthcare sector. health. The Continuous Veno-Venous Hemodiafiltration (CVVHDF) market is expected to grow at the fastest rate among all modalities during the analysis period. The CVVHDF treatment modality leads to the complete elimination and replacement of fluids and blood in the blood. The modality combines the principles of convection and diffusion, hemodialysis and hemofiltration, using an efficient hemodiafilter. Considering the modality’s ability to remove both solutes and fluids, the CVVHDF segment is poised to grow at a steady pace in the coming years. CVVHDF is a modality that is generally preferred among hospitals with well-established intensive care units. After

MarketGlass™ Platform
Our MarketGlass™ platform is a free comprehensive knowledge center that can be custom configured to meet the intelligence needs of today’s busy business executives! This interactive, influencer-focused research platform is at the heart of our core research engagements and draws on the unique perspectives of participating executives from around the world. Features include – enterprise-wide peer-to-peer collaborations; overviews of research programs relevant to your business; 3.4 million profiles of experts in the field; profiles of competitive companies; interactive research modules; custom report generation; follow market trends; competing brands; create and publish blogs and podcasts using our primary and secondary content; follow domain events around the world; and much more. Client companies will have privileged access to the project’s data stacks. Currently used by over 67,000 domain experts worldwide.

Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our mobile application which has just been released on iOS or android

About Global Industry Analysts, Inc. and StrategyR™
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher, the only influencer-focused market research company in the world. Proudly serving over 42,000 clients in 36 countries, GIA has been recognized for its accurate forecasting of markets and industries for over 33 years.

CONTACTS:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
www.StrategyR.com
E-mail: [email protected]

CONNECTIONS
Join our group of experts
https://www.strategyr.com/Panelist.asp

Connect with us on LinkedIn
https://www.linkedin.com/company/global-industry-analysts-inc./

Follow us on twitter
https://twitter.com/marketbytes

Journalists and media
[email protected]

SOURCE Global Industry Analysts, Inc.

About Myra R.

Check Also

The unfair and discriminatory face of corruption

Corruption increases injustice and discrimination; its impact is multidimensional. Grand corruption, the collusive abuse of …